Abstract
Major depressive disorder (MDD) is a common disorder that presents a clinical challenge in terms of both acute and long term treatment. Residual symptoms are common and lead to high relapse rates in the short term and disability in the longer term.
Original language | English |
---|---|
Pages (from-to) | S397 |
Journal | European Neuropsychopharmacology |
Volume | 23 |
Issue number | Supplement 2 |
DOIs | |
State | Published - 2013 |